Detalles de la búsqueda
1.
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
Lancet Oncol
; 24(12): 1321-1333, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37949086
2.
VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study.
Clin Infect Dis
; 76(7): 1304-1310, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36358012
3.
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants.
NPJ Vaccines
; 9(1): 41, 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38383584
4.
A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India.
Vaccine X
; 14: 100300, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37128477
5.
A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
Vaccine X
; 14: 100313, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37234594
6.
Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactin.
Front Immunol
; 14: 1190404, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37342321
7.
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany.
Vaccine
; 2023 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37827966
8.
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India.
Expert Rev Vaccines
; 22(1): 278-287, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883291
9.
A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16-24 months.
Hum Vaccin Immunother
; 18(6): 2146435, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36412272
10.
Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children.
Hum Vaccin
; 7(4): 451-7, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21403463
11.
Vaccines For Type 1 Diabetes: Prevention or Reversal?
Curr Diabetes Rev
; 17(1): 30-36, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32223735
12.
A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
Vaccine
; 39(6): 882-885, 2021 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33423838
13.
A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer.
Urol Oncol
; 38(5): 433-439, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32037199
14.
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy.
Oncoimmunology
; 9(1): 1748981, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32363120
15.
Safety and immunogenicity of diphtheria-tetanus-pertussis vaccine and hepatitis B vaccine as a new tetravalent combination (DTwP/HB) administered alone and at separate sites (DTwP and HB) including comparison with standard commercially available combination vaccine in Indian infants 6-14 weeks of age.
Hum Vaccin
; 5(5): 310-4, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18849664
16.
Safety and immunogenicity of an indigenously developed Haemophilus influenzae type b conjugate vaccine through various phases of clinical trials.
Hum Vaccin
; 5(7): 483-7, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19395868
17.
Post-marketing surveillance study to assess the safety and tolerability of an Inactivated Poliomyelitis Vaccine in Indian children.
Hum Vaccin Immunother
; 13(11): 2538-2542, 2017 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28846490
18.
Th1-Th2 Seesaw: An Essential Aspect in Type 1 Diabetes.
Curr Diabetes Rev
; 18(8): e080322201918, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260057
19.
Sero-surveillance to assess rubella susceptibility and assessment of immunogenicity and reactogenicity of rubella vaccine in Indian girls aged 18-24 years.
Hum Vaccin Immunother
; 10(10): 2813-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25483461
20.
Antibody persistence of two pentavalent DTwP-HB-Hib vaccines to the age of 15-18 months, and response to the booster dose of quadrivalent DTwP-Hib vaccine.
Vaccine
; 31(3): 444-7, 2013 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-23196204